-
Switzerland: Qualitative Results Published, Showing Lasting Benefits
-
LSD Annual Report Submitted to FDA
-
LSD Study Breaks 40 Years of Research Taboo
-
Switzerland: Results Published in Journal of Nervous Mental Disease
-
Switzerland: Paper Accepted for Publication in Journal of Nervous and Mental Disease
-
Final Report Submitted to SwissMedic
-
Paper Resubmitted for Publication after Editorial Rejection
-
Results Submitted for Publication in Peer-Reviewed Journal
-
LSD-Assisted Therapy for Anxiety Associated with Advanced Illness: Closeout Visit Conducted
-
LSD-Assisted Therapy for Anxiety: Last Follow-Up Interviews Complete
-
Shaping the Renaissance of Psychedelic Research
-
LSD-Assisted Therapy for End-of-Life Anxiety: Annual Report Submitted to FDA
-
Last Two-Month Follow-Up Completed in Swiss Study of LSD Psychotherapy Study
-
Last Subject Treated in Swiss Study of LSD-Assisted Therapy for End-of-Life Anxiety
-
Swiss LSD Study Team Submits Annual Report to FDA; Study Nears Completion
-
Swiss LSD Study in Final Stages
-
Twelfth and Final Subject Enrolled in Swiss LSD Study
-
Twelfth and Final Subject to be Screened for Swiss LSD Study
-
MAPS Grants $10K to Beckley Psilocybin/Brain Imaging Study
-
Swiss IRB Approves Subjects with Life-Shortening Illnesses: Parkinsons and Bechterews Disease